EUVIMEDEUVIMED entdecken
Open Access

Identification of Preclinical Biomarkers of Metabolic Dysfunction–Associated Steatotic Liver Disease versus Metabolic Dysfunction and Alcohol-Associated Liver Disease and the Impact of Diet

Tyler C Gripshover, Rui S Treves, Josiah E Hardesty

The American Journal of Pathology · 2026

DOI: 10.1016/j.ajpath.2025.05.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Pathology, 2026. Verfasst von Tyler C Gripshover und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky. Hauptthemen laut MEDLINE: Biomarkers, Liver Diseases, Alcoholic, Fatty Liver, Fatty Liver, Alcoholic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersLiver Diseases, AlcoholicFatty LiverFatty Liver, AlcoholicAnimalsMaleMice, Inbred C57BLMiceDiet, High-FatDisease Models, AnimalGastrointestinal MicrobiomeLiverEthanol

Substanzen

BiomarkersEthanol

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky.
  • Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky; University of Louisville Alcohol Research Center, University of Louisville School of Medicine, Louisville, Ke…

Förderung

  • NIAAA NIH HHS
  • National Institutes of Health
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Gripshover, T. C., Treves, R. S., & Hardesty, J. E. (2026). Identification of Preclinical Biomarkers of Metabolic Dysfunction–Associated Steatotic Liver Disease versus Metabolic Dysfunction and Alcohol-Associated Liver Disease and the Impact of Diet. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2025.05.013

Vancouver

Gripshover TC, Treves RS, Hardesty JE. Identification of Preclinical Biomarkers of Metabolic Dysfunction–Associated Steatotic Liver Disease versus Metabolic Dysfunction and Alcohol-Associated Liver Disease and the Impact of Diet. The American Journal of Pathology. 2026. doi:10.1016/j.ajpath.2025.05.013

BibTeX
@article{Gripshover2026,
  author = {Gripshover, Tyler C and Treves, Rui S and Hardesty, Josiah E},
  title = {Identification of Preclinical Biomarkers of Metabolic Dysfunction–Associated Steatotic Liver Disease versus Metabolic Dysfunction and Alcohol-Associated Liver Disease and the Impact of Diet},
  journal = {The American Journal of Pathology},
  year = {2026},
  doi = {10.1016/j.ajpath.2025.05.013}
}
Kostenlos starten →